These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20971158)

  • 21. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.
    Li X; Rosborough KM; Friedman AB; Zhu W; Roth KA
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):7-19. PubMed ID: 16672106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine/fluoxetine combination for bipolar depression and other mood disorders: a review.
    Owen RT
    Drugs Today (Barc); 2006 Mar; 42(3):185-92. PubMed ID: 16628260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of fluoxetine on olanzapine pharmacokinetics.
    Gossen D; de Suray JM; Vandenhende F; Onkelinx C; Gangji D
    AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute administration of l-tyrosine alters energetic metabolism of hippocampus and striatum of infant rats.
    Ramos AC; Ferreira GK; Carvalho-Silva M; Furlanetto CB; Gonçalves CL; Ferreira GC; Schuck PF; Streck EL
    Int J Dev Neurosci; 2013 Aug; 31(5):303-7. PubMed ID: 23602810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic betahistine co-treatment reverses olanzapine's effects on dopamine D₂ but not 5-HT2A/2C bindings in rat brains.
    Lian J; Huang XF; Pai N; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():75-80. PubMed ID: 25149912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain creatine kinase activity is increased by chronic administration of paroxetine.
    Santos PM; Scaini G; Rezin GT; Benedet J; Rochi N; Jeremias GC; Carvalho-Silva M; Quevedo J; Streck EL
    Brain Res Bull; 2009 Dec; 80(6):327-30. PubMed ID: 19772902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of citrate synthase activity in brain of rats submitted to an animal model of mania induced by ouabain.
    Freitas TP; Rezin GT; Gonçalves CL; Jeremias GC; Gomes LM; Scaini G; Teodorak BP; Valvassori SS; Quevedo J; Streck EL
    Mol Cell Biochem; 2010 Aug; 341(1-2):245-9. PubMed ID: 20372980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice.
    Klenotich SJ; Seiglie MP; McMurray MS; Roitman JD; Le Grange D; Dugad P; Dulawa SC
    Neuropsychopharmacology; 2012 Jun; 37(7):1620-31. PubMed ID: 22395732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging brain phospholipase A2-mediated signal transduction in response to acute fluoxetine administration in unanesthetized rats.
    Qu Y; Chang L; Klaff J; Seemann R; Rapoport SI
    Neuropsychopharmacology; 2003 Jul; 28(7):1219-26. PubMed ID: 12784122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoxetine Adjunctive Therapy for Obsessive-Compulsive Symptoms Associated With Olanzapine in Schizophrenic Patients.
    Figueiredo T; Segenreich D; Mattos P
    J Clin Psychopharmacol; 2016 Aug; 36(4):389-91. PubMed ID: 27285659
    [No Abstract]   [Full Text] [Related]  

  • 31. Brain energy metabolism parameters in an animal model of diabetes.
    Ceretta LB; Réus GZ; Rezin GT; Scaini G; Streck EL; Quevedo J
    Metab Brain Dis; 2010 Dec; 25(4):391-6. PubMed ID: 21088877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of fluoxetine plus olanzapine treatment in rats: a behavior, endocrine, and immediate-early gene expression analysis.
    Horowitz JM; Goyal A; Ramdeen N; Hallas BH; Horowitz AT; Torres G
    Synapse; 2003 Dec; 50(4):353-64. PubMed ID: 14556240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olanzapine, but not haloperidol, enhances PSA-NCAM immunoreactivity in rat prefrontal cortex.
    Frasca A; Fumagalli F; Ter Horst J; Racagni G; Murphy KJ; Riva MA
    Int J Neuropsychopharmacol; 2008 Aug; 11(5):591-5. PubMed ID: 18593508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine.
    De La Garza R; Jentsch JD; Verrico CD; Roth RH
    Brain Res; 2002 Dec; 958(1):20-7. PubMed ID: 12468026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers.
    Hroudova J; Fisar Z
    Neuro Endocrinol Lett; 2010; 31(3):336-42. PubMed ID: 20588251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity.
    Sacchi S; Novellis V; Paolone G; Nuzzo T; Iannotta M; Belardo C; Squillace M; Bolognesi P; Rosini E; Motta Z; Frassineti M; Bertolino A; Pollegioni L; Morari M; Maione S; Errico F; Usiello A
    Sci Rep; 2017 Apr; 7():46288. PubMed ID: 28393897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
    Hervás I; Artigas F
    Eur J Pharmacol; 1998 Sep; 358(1):9-18. PubMed ID: 9809863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABA, glutamate, dopamine and serotonin transporters expression on memory formation and amnesia.
    Tellez R; Gómez-Víquez L; Meneses A
    Neurobiol Learn Mem; 2012 Feb; 97(2):189-201. PubMed ID: 22183017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combination of olanzapine and fluoxetine in mood disorders.
    Shelton RC
    Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs.
    Lin D; Koob GF; Markou A
    Psychopharmacology (Berl); 1999 Aug; 145(3):283-94. PubMed ID: 10494577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.